Document is current
Any future updates will be listed below
-
Authors
Wasserman, Jason S.
Fowle, Holly
Hashmi, Rumesa
Atar, Diba
Patel, Kishan R.
Yarmahmoodi, Amir
Macfarlane, Alexander W.
Tan, Yinfei
Cukierman, Edna
Gligorijevic, Bojana
Karami, Adam
Whelan, Kelly A.
Campbell, Kerry S.
Graña, Xavier
-
Funding
Funding for this research was provided by:
NCI (Pre-Pilot Award from U54 CA221704, P30CA006927, R03 CA216134-01)
National Institute of General Medical Sciences (R01 GM117437)
WW Smith Charitable Trust Award
- License Information
-
More Information
Article History
Received: 19 April 2024
Accepted: 27 August 2024
First Online: 2 September 2024
Competing interests
: No, I declare that the authors have no competing interests as defined by Nature Research, or other interests that might be perceived to influence the results and/or discussion reported in this paper. The authors declare no potential conflicts of interest.
: This study uses human cell lines and primary hPrEC (Human Primary Prostate Epithelial Cells), which were obtained from the American Type Culture Collection. All tissues ATCC uses for isolation of primary cells are obtained under informed consent and conform to HIPAA regulations to protect the privacy of the donor’s Personally Identifiable Information. All experiments were conducted in accordance with ethical guidelines and approved by Temple University Institutional Biosafety Committee (IBC-11160).
